ArticleActive
Response to Comments: Molecular Diagnostic Tests(MDTs) L36021
A54584
Effective: October 1, 2015
Updated: December 31, 2025
Policy Summary
CGS Administrators received no comments on draft DL36021 for Molecular Diagnostic Tests (MDTs). Consequently, this notice does not introduce or change any coverage indications, limitations, documentation requirements, or frequency limits for MDTs.